These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8211800)

  • 1. [The efficacy and safety of the drug treatment of cardiovascular diseases].
    Mazur NA
    Ter Arkh; 1993; 65(8):4-7. PubMed ID: 8211800
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety in clinical trials in cardiovascular disease.
    Cohn JN
    J Am Coll Cardiol; 2006 Aug; 48(3):430-3. PubMed ID: 16875964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interactions of cardiac and antiretroviral medication].
    Egger S; Drewe J
    Herz; 2005 Sep; 30(6):493-503. PubMed ID: 16170680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bibliography. Current world literature. Clinical trials.
    Curr Opin Cardiol; 2008 Jul; 23(4):407-21. PubMed ID: 18520727
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rationale for the pharmacologic treatment of cardiovascular diseases].
    Perdigão C
    Rev Port Cardiol; 1998 May; 17(5):453-61. PubMed ID: 9656768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matching the standards of clinical trial evidence with application in practice.
    Sharpe N
    Int J Clin Pract; 2002 Dec; 56(10):772-5. PubMed ID: 12510951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinued drugs in 2008: cardiovascular drugs.
    Zhang XS; Xiang BR
    Expert Opin Investig Drugs; 2009 Jul; 18(7):875-85. PubMed ID: 19548849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular pharmacology in the 90s: where are we?].
    Marín Huerta E; Rayo I
    Rev Esp Cardiol; 1994 Jun; 47(6):390-402. PubMed ID: 8066311
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse dermatologic effects of cardiovascular drug therapy.
    Brosnan BD; Frishman WH; Sun DK; Grossman M
    Heart Dis; 2000; 2(3):220-47. PubMed ID: 11728264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETC-588 (Pfizer).
    Doggrell SA
    Curr Opin Investig Drugs; 2004 Sep; 5(9):993-9. PubMed ID: 15503656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic implications of the gender-specific aspects of cardiovascular disease.
    Regitz-Zagrosek V
    Nat Rev Drug Discov; 2006 May; 5(5):425-38. PubMed ID: 16672926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apixaban, an oral, direct inhibitor of activated Factor Xa.
    Shantsila E; Lip GY
    Curr Opin Investig Drugs; 2008 Sep; 9(9):1020-33. PubMed ID: 18729009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of randomised clinical trials of cardiovascular generic versus brand name drugs.
    Cardiovasc J Afr; 2009; 20(2):143. PubMed ID: 19421653
    [No Abstract]   [Full Text] [Related]  

  • 14. Problems and pitfalls in cardiac drug therapy.
    Stone SM; Rai N; Nei J
    Rev Cardiovasc Med; 2001; 2(3):126-42. PubMed ID: 12439377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant vitamins: getting to the heart of the matter.
    Scott RS
    N Z Med J; 1996 Aug; 109(1028):324. PubMed ID: 8816728
    [No Abstract]   [Full Text] [Related]  

  • 16. [20 years of cardiovascular epidemiology. The clinician's viewpoint].
    Bertrand ME
    Rev Epidemiol Sante Publique; 1996 Nov; 44(6):556-62. PubMed ID: 9005491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of alternative pharmacotherapy in management of cardiovascular diseases.
    Chagan L; Ioselovich A; Asherova L; Cheng JW
    Am J Manag Care; 2002 Mar; 8(3):270-85; quiz 286-8. PubMed ID: 11924555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corporate influence over planning and presentation of clinical trials: beauty and the beast.
    Fuchs FD
    Expert Rev Cardiovasc Ther; 2010 Jan; 8(1):7-9. PubMed ID: 20014930
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methods of evaluating drug therapy, particularly in cardiovascular diseases].
    Lövy O; Toman J
    Cesk Zdrav; 1984 Sep; 32(8-9):361-5. PubMed ID: 6509673
    [No Abstract]   [Full Text] [Related]  

  • 20. [Health and longevity by one tablet daily. Fiction and hard facts on the polypill].
    Holzgreve H
    MMW Fortschr Med; 2014 Jan; 156(1):55-7. PubMed ID: 24930311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.